MOUNIR ABDELSHAHID: Open Payments
NPI 1780872838 · BLOOMFIELD, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$925 in 47 payments from 17 companies in 2025. Trend: 2023 $1,057 · 2024 $839 · 2025 $925
Food & beverage: $925
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 4 | $202 |
| GlaxoSmithKline, LLC. | 11 | $189 |
| Almatica Pharma LLC | 6 | $91 |
| Merck Sharp & Dohme LLC | 5 | $83 |
| ABBVIE INC. | 4 | $61 |
| Xeris Pharmaceuticals, Inc. | 3 | $58 |
| Insulet Corporation | 3 | $55 |
| Amgen Inc. | 2 | $29 |
| Otsuka America Pharmaceutical, Inc. | 1 | $23 |
| ACADIA Pharmaceuticals Inc | 1 | $20 |
Products named: TRELEGY ELLIPTA, FARXIGA, LOREEV XR, VERQUVO, CREON, Omnipod, RECORLEV, BREZTRI.
Industry payments across NJ — which companies pay providers there.
